Early research (Phase 1)Study completedNCT01854606
What this trial is testing
Safety and Efficacy of AEB071 and EVEROLIMUS in Patients With CD79-mutant or ABC Subtype Diffuse Large B-Cell Lymphoma
Who this might be right for
CD79 Mutant or ABC-subtype Diffuse Large B-Cell Lymphoma
Novartis Pharmaceuticals 31